ORIGINAL RESEARCH article

Front. Pharmacol., 04 March 2024

Sec. Pharmacology of Anti-Cancer Drugs

Volume 15 - 2024 | https://doi.org/10.3389/fphar.2024.1356639

Effect of aromatic substituents on thermoresponsive functional polycaprolactone micellar carriers for doxorubicin delivery

  • HW

    Hanghang Wang

  • HP

    Himanshu Polara

  • AB

    Abhi Bhadran

  • TS

    Tejas Shah

  • GK

    Godwin Kweku Babanyinah

  • ZM

    Ziyuan Ma

  • EL

    Erika L. Calubaquib

  • JT

    Justin T. Miller

  • MC

    Michael C. Biewer *

  • MC

    Mihaela C. Stefan *

  • Department of Chemistry and Biochemistry, University of Texas at Dallas, Richardson, TX, United States

Abstract

Amphiphilic functional polycaprolactone (PCL) diblock copolymers are excellent candidates for micellar drug delivery. The functional groups on the backbone significantly affect the properties of PCL. A systematic investigation of the effect of aromatic substituents on the self-assembly of γ-functionalized PCLs and the delivery of doxorubicin (DOX) is presented in this work. Three thermoresponsive amphiphilic diblock copolymers with poly(γ-benzyloxy-ε-caprolactone) (PBnCL), poly(γ-phenyl- ε-caprolactone) (PPhCL), poly(γ-(4-ethoxyphenyl)-ε-caprolactone) (PEtOPhCL), respectively, as hydrophobic block and γ-tri(ethylene glycol) functionalized PCL (PME3CL) as hydrophilic block were prepared through ring-opening polymerization (ROP). The thermoresponsivity, thermodynamic stability, micelle size, morphology, DOX-loading, and release profile were determined. The LCST values of amphiphilic diblock copolymers PME3CL-b-PBnCL, PME3CL-b-PPhCL, and PME3CL-b-PEtOPhCL are 74.2°C, 43.3°C, and 37.3°C, respectively. All three copolymers formed spherical micelles in phosphate-buffered saline (PBS, 1×, pH = 7.4) at low concentrations ranging from 8.7 × 10−4 g/L to 8.9 × 10−4 g/L. PME3CL-b-PBnCL micelles showed the highest DOX loading capacity of 3.01 ± 0.18 (wt%) and the lowest drug release, while PME3CL-b-PEtOPhCL micelles exhibited the lowest DOX loading capacity of 1.95 ± 0.05 (wt%) and the highest drug release. Cytotoxicity and cellular uptake of all three micelles were assessed in vitro using MDA-MB-231 breast cancer cells. All three empty micelles did not show significant toxicity to the cells at concentrations high up to 0.5 mg/mL. All three DOX-loaded micelles were uptaken into the cells, and DOX was internalized into the nucleus of the cells.

1 Introduction

Polymeric micelles formed from polycaprolactone (PCL)-based amphiphilic diblock copolymers can be employed in drug delivery applications due to their biocompatibility and (bio)degradability. (; ; ; ; ). The micelles can physically pack poorly water-soluble drugs in their hydrophobic core and stabilize them in aqueous solutions with the help of their hydrophilic shell. The functional groups on the PCL diblock copolymers can be varied to adjust the properties of polymeric micelles, including hydrophilicity, thermodynamic stability, drug loading capacity, and site targeting. ().

The hydrophilicity of polymeric micelles is important for drug delivery because it allows the micelles to solubilize in the bloodstream and reduces reticuloendothelial system clearance. (). Hydrophilic functional groups such as N-isopropylamide () and oligo(ethylene glycol) (OEG) (; ) were reported to provide hydrophilicity to PCL-based polymers. Dai et al. () compared the water absorbance rate of a N-isopropylamide functionalized PCL copolymer and an unfunctionalized PCL polymer. The functionalized PCL bearing 9.1 mol% N-isopropyl-2-carbamoylethyl group absorbed 43.2 wt% water after 70 days, more than 80 times the water absorbed by the unfunctionalized PCL. However, no micelle preparation was performed. Calubaquib et al. () synthesized OEG functionalized PCL homopolymers and obtained thermoresponsive polymeric micelles with lower critical solution temperature (LCST) in water. The OEG groups contributed hydrophilicity and thermoresponsivity to the micelles, and those properties were easily tuned by varying the length of the OEG groups. It is beneficial to use thermoresponsive micelles for drug delivery, considering the potential enhancement of therapeutic efficacy by thermal-controlled drug release. The desired LCST of thermoresponsive micelles is slightly above the body temperature. Unfortunately, the OEG functionalized PCL homopolymers (>58°C) are unsuitable for drug delivery due to undesired high LCST. (). Soltantabar and Calubaquib et al. () also reported thermosensitive polymeric micelles prepared by OEG-functionalized PCL copolymers in water. The LCST was tuned to 15°C–59°C by adding a hydrophobic block, and thermal-controlled release of the anticancer drug doxorubicin was achieved. ().

Thermodynamic stability is also of great value when selecting suitable polymeric micelles for drug delivery because they should maintain their form to prevent premature drug release upon dilution after intravenous injection into the bloodstream. The desired CMC is below10−3 g/L, (), and it can be tuned by varying the functional groups on the copolymer (; ) and by adjusting the ratio of the two blocks of amphiphilic diblock copolymers. (; ; ; ).

Drug loading capacity (DLC) is another essential consideration for micellar drug delivery. Higher drug loading capacities reduce the number of carrier materials for a given drug dosage, improving production and administration and mitigating concerns about the pharmacological effect of the carrier material. DLC can be affected by the hydrophobic functional groups on the polymers. (; Yan et al., 2010; ; ; Yan et al., 2011; ; ; ; ; Zhang et al., 2014; ; ; ; ; ; ; ; ; ). This is attributed to the interactions between the drug payload and the hydrophobic micellar core. (). A practical approach to increasing the DLC of drugs containing aromatic rings is to enhance the π-π stacking interaction between the drug payload and the hydrophobic micellar core. (). Yan et al. (Yan et al., 2011) reported carbamic acid benzyl ester (CAB) functionalized PCL-based diblock copolymers for the delivery of doxorubicin (DOX). The DLC of the copolymers increased from 19.0% to 25.5% with the increase in the content of the CAB group. Peng et al. () obtained a higher DLC of indomethacin, a nonsteroidal anti-inflammable drug, using phenyl functionalized PCL-based diblock copolymers versus unfunctionalized PCL copolymers. Washington et al. () investigated the DOX loading capacity of benzyloxy functionalized PCL-based diblock copolymer, which was 2.2 times more than that of the unfunctionalized PCL copolymers. The high DLC of functionalized PCL copolymers was attributed to the enhanced π-π stacking interactions between DOX and the hydrophobic benzyloxy functional groups on the copolymers.

As mentioned earlier, PCL-based amphiphilic diblock copolymers bearing aromatic functional groups can increase the DLC of micelles. However, to our knowledge, a systematic comparison of the influence of analogous aromatic functional groups on micellization, thermodynamic stability, drug loading, release, and cytotoxicity has yet to be studied. Therefore, we systematically investigated the effect of three analogous aromatic substituents on the self-assembly behaviors of γ-functionalized PCL diblock copolymers and the delivery of DOX. Tri(ethylene glycol) functionalized PCL (PME3CL) was used as a hydrophilic block, and γ-aromatic group functionalized PCLs bearing benzyloxy, phenyl, and 4-ethoxyphenyl groups were utilized as hydrophobic blocks. The tri(ethylene glycol) (ME3) functional group was used to provide hydrophilicity and thermoresponsivity to the diblock copolymers. The aromatic functional groups are significantly different in flexibility, and it decreased in the order of benzyloxy (Bn) > 4-ethoxyphenyl (EtOPh) > phenyl (Ph). The effect of the flexibility and steric of the hydrophobic aromatic substituents on the critical micellar concentration (CMC), LCST, DOX loading, and release was assessed. In vitro studies of cytotoxicity and cellular uptake were carried out on MDA-MB-231 breast cancer cells.

2 Materials and methods

2.1 Materials

All chemicals were obtained from Sigma-Aldrich or Fisher Scientific. Prior to use, benzyl alcohol (BnOH) was purified by vacuum distillation. Chloroform was dried over calcium hydride (CaH2) and purified by vacuum distillation. All glassware used for polymerizations was kept in an oven heated at 120°C for 24 h and cooled down in a desiccator before use. The monomers were dried with CaH2 before polymerization. The ring-opening polymerization (ROP) was performed in a glovebox at room temperature. The hydrophilic monomer γ-tri(ethylene glycol) ε-caprolactone (γ-ME3CL) (; ) and the hydrophobic monomers γ-benzyloxy ε-caprolactone (γ-BnCL) (; ) and γ-phenyl ε-caprolactone (γ-PhCL) () were synthesized following the reported procedure in the literature. The new hydrophobic monomer γ-4-ethoxyphenyl ε-caprolactone (γ-EtOPhCL) was prepared following a two-step synthetic route (Supplementary Scheme S1).

2.2 Analysis

A Bruker AVANCE III (500 MHz) nuclear magnetic resonance (NMR) instrument was used to collect 1H and 13C spectra using CDCl3 as the solvent. Size exclusion chromatography (SEC) measurements were obtained using a Shimadzu HPLC instrument equipped with an Agilent column connected to the Shimadzu refractive index detector with N, N-dimethylformamide (DMF) as eluent, and poly(methyl methacrylate) (PMMA) standard calibration. Differential scanning calorimetry (DSC) was performed on a TA Instruments Q100 DSC under nitrogen at 20 mL/min. A temperature-controlled Cary5000 UV-vis spectrometer was used for the turbidimetric assay of the synthesized polymers. A 0.5°C min-1 heating rate was applied, and a quartz cuvette with a path length of 1.0 cm was used. Fluorescence spectroscopy was performed using a Perkin-Elmer LS 50 BL luminescence spectrometer. The size and distribution of the particles were measured through dynamic light scattering (DLS) using the Malvern Zetasizer Nano ZS instrument equipped with a He-Ne laser (633 nm) and a 173° backscatter detector. Transmission electron microscopy (TEM) analysis was conducted using a JEM-1400+ TEM (JEOL United States Inc., MA) with 2% phosphotungstic acid stain. A Biotek Cytation 3 imaging reader was used to perform cell viability and cellular uptake measurements.

2.3 Synthesis of polymers

2.3.1 Synthesis of diblock copolymer poly{γ-2-[2-(2-methoxyethoxy)ethoxy]ethoxy-ε-caprolactone}-b-poly(γ-benzyloxy-ε-caprolactone) (PME3CL-b-PBnCL)

In a 10 mL round bottom flask, organocatalyst triazabicylo[4.4.0]dec-5-ene (TBD) (5.57 mg, 0.04 mmol) and benzyl alcohol (BnOH) initiator (4.33 mg, 0.04 mmol) in dry chloroform were stirred for 30 min. Then, the hydrophilic γ-ME3CL monomer (552.66 mg, 2.00 mmol) was added to the flask. After complete conversion, the hydrophobic γ-BnCL monomer (440.54 mg, 2.00 mmol) was added. The reaction was stirred till the second monomer was fully converted. Then the polymerization was quenched by exposing it to air and adding acetic acid. The polymer was obtained by precipitation in hexane/THF. 1H NMR (500 MHz, CDCl3): δ 1.76–1.95 (m, 8H), 2.31–2.46 (m, 4H), 3.37 (s, 3H), 3.45–3.72 (m, 14H), 4.09–4.21 (m, 4H), 4.42–4.55 (m, 2H), 7.30–7.38 (m, 5H). 13C NMR (500 MHz, CDCl3): δ 28.79, 29.09, 29.68, 29.76, 32.85, 33.11, 59.02, 61.26, 61.33, 68.54, 70.55, 70.63, 70.72, 71.08, 71.95, 74.60, 74.65, 75.80, 127.67, 127.78, 128.39, 138.29, 173.39, 173.39, 173.44. Mn = 5600, PDI = 1.67.

2.3.2 Synthesis of diblock copolymer poly{γ-2-[2-(2-methoxyethoxy)ethoxy]ethoxy-ε-caprolactone}-b-poly(γ-phenyl-ε-caprolactone) (PME3CL-b-PPhCL)

A similar method was used to synthesize amphiphilic diblock copolymer PME3CL-b-PPhCL: 1H NMR (500 MHz, CDCl3): δ 1.76–1.97 (m, 8H), 1.99–2.04 (m, 2H), 2.37–2.41 (m, 2H), 2.54–2.58 (q, 1H), 3.37 (s, 3H), 3.44–3.48 (q, 1H), 3.53–3.65 (m, 12H), 3.77–3.88 (m, 2H), 4.15–4.18 (t, 2H), 7.02–7.22 (m, 5H). 13C NMR (500 MHz, CDCl3): δ 29.09, 29.76, 31.60, 32.09, 32.11, 33.11, 35.39, 42.18, 59.02, 61.32, 62.63, 68.54, 70.56, 70.63, 70.73, 71.95, 75.79, 126.68, 127.56, 128.63, 143.01, 173.23, 173.44. Mn = 9600, PDI = 1.95.

2.3.3 Synthesis of diblock copolymer poly{γ-2-[2-(2-methoxyethoxy)ethoxy]ethoxy-ε-caprolactone}-b-poly(γ-(4-ethoxylphenyl)-ε-caprolactone) (PME3CL-b-PEtOPhCL)

A similar method was used to synthesize amphiphilic diblock copolymer PME3CL-b-PEtOPhCL: 1H NMR (500 MHz, CDCl3): δ 1.38–1.41 (t, 3H), 1.77–1.90 (m, 8H), 1.99–2.01 (m, 2H), 2.37–2.43 (m, 2H), 2.48–2.57 (m, 1H), 3.37 (s, 3H), 3.44–3.49 (m, 1H), 3.53–3.65 (m, 12H), 3.73–3.87 (m, 2H), 3.96–3.99 (t, 2H), 4.15–4.17 (t, 2H), 6.79–6.13C NMR (500 MHz, CDCl3): δ 14.90, 29.09, 29.74, 31.78, 32.17, 33.10, 35.54, 41.29, 59.03, 61.32, 62.67, 63.36, 68.54, 70.56, 70.63, 70.72, 71.95, 75.78, 114.59, 128.41, 134.75, 157.66, 173.36, 173.45. Mn = 9300, PDI = 1.95.

2.4 Determination of CMC

The CMC was determined by using pyrene as a hydrophobic fluorescence probe. A series of aqueous polymer solutions in phosphate-buffered saline (PBS, 1×, pH = 7.4) with varying polymer concentrations and a constant pyrene concentration were prepared using THF stock solutions of polymers and pyrene. THF was removed by vigorous stirring and evaporation. The final polymer concentrations were 10−8 to 1 g/L, and the final pyrene concentration was 6.55 × 10−7 M. Then, the pyrene-loaded micelle aqueous solutions were subjected to a fluorescence spectrometer to collect fluorescence excitation spectra (emission at 390 nm).

2.5 Determination of LCST

The LCST was determined by using a temperature-controlled UV-Vis spectrometer. Polymers were directly dissolved in phosphate-buffered saline (PBS, 1×, pH = 7.4) and equilibrated for 24 h. Then, the aqueous polymer solutions (1 mg/mL) were subjected to a temperature-controlled UV-Vis spectrometer to record transmittance with temperature change.

2.6 Micelle preparation

Empty micelles were prepared by the solvent evaporation method. A 1.5 mL THF polymer solution was added dropwise to 5 mL phosphate-buffered saline (PBS, 1×, pH = 7.4) while homogenizing for 15 min. Then, the THF was evaporated by vortex, and micelle solutions were obtained by filtration using a 0.45 µm nylon filter. The final polymer concentration was 1 mg/mL.

2.7 Drug loading

DOX-loaded micelles were prepared using the solvent evaporation method. DOX. HCl solution was neutralized by adding three equiv. of triethylamine in THF. To 5 mL phosphate-buffered saline (PBS, 1×, pH = 7.4), a 1.5 mL THF solution of 5 mg polymer and 0.5 mg DOX was added dropwise with homogenization for 15 min. THF was removed by vortex, and DOX-loaded micelle solution (1 mg/mL) was obtained by filtration using a 0.45 µm nylon filter. To determine drug loading capacity (DLC) and drug loading efficiency (DLE), the DOX-loaded micelles were first disassembled by DMSO and then subjected to a UV-Vis spectrometer to record absorbance spectra. The concentration of DOX was determined by fitting absorbance readout at 485 nm to a pre-plotted absorbance vs. DOX concentration in DMSO:PBS (1:1) calibration curve. DLC and DLE were calculated using the equations listed below.

2.8 Size and morphology analysis

The micelle size was measured by dynamic light scattering (DLS). After micelles preparation in PBS with a concentration of 1 mg/mL, samples were equilibrated at 25°C in a Malvern Zetasizer Nano ZS instrument to measure the hydrodynamic diameters (Dh) of micelles. Morphological studies of the micelle solution were carried out by Transmission Electron Microscopy (TEM). 2 wt% phosphotungstic acid (PTA) solution was used to stain the micelles to analyze the morphology.

2.9 Determination of in vitro drug release

Freshly prepared DOX-loaded micelles with a polymer-to-DOX feed ratio of 10:1 were used to determine the release profile at various conditions. The loaded micelle solution (4 mL), with a constant concentration of polymer at 1 mg/mL, was transferred to a SnakeSkin® dialysis tubing with a MW cutoff of 3500 Da and was dialyzed against 10 mL of PBS at a pH of 7.4 for 48 h at 37°C. At specific intervals, 0.3 mL of the release media was removed and replaced with fresh PBS. Each sample was diluted with DMSO and analyzed to quantify the amount of DOX released based on the pre-established calibration curve using UV−Vis spectroscopy. Absorbance measurements in the release media were taken at 485 nm to calculate the cumulative DOX release.

2.10 Biological studies

Unless otherwise indicated, all cell culture experiments were performed using Dulbecco’s Modified Eagle Medium (DMEM) medium with 10% fetal bovine serum (FBS) and 1% penicillin–streptomycin. Cells were grown in a humidified environment at 37°C with 5% CO2.

2.10.1 Cytotoxicity studies

MDA-MB-231 Breast cancer (ATCC, HTB-26) cells were cultured in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin (pen/strep). The cells were seeded in a 96-well plate at a density of 1 × 104 cells per well in 100 μL growth medium. Cells were allowed to adhere to the bottom of the wells by incubation at 37°C at 5% CO2 for 24 h. The medium was then removed, and the cells were washed with PBS. A total of 80 μL of DOX-loaded micelle (in PBS) of different concentrations were added to each well, followed by an additional 100 μL of fresh media. After 24 h of incubation at 37°C, the media containing drug-loaded micelles were removed, and the cells were washed twice using PBS. The cells were treated with 30 μL of 12 mM methylthiazolyldiphenyl-tetrazolium bromide (MTT) (Thermo Fisher Scientific, United States of America) in PBS and incubated for 5 h at 37°C and 5% CO2 in the dark to form formazan crystals. The formazans were dissolved using 170 μL of dimethyl sulfoxide (DMSO). The absorption was recorded at 540 nm and normalized to the intensity of the untreated cells (N = 5, standard deviation). Statistical analysis was performed with one-way ANOVA using GraphPad Prism. The value of p < 0.05 was considered statistically significant.

2.10.2 Cellular uptake

MBA-MB-231 cells were cultured in a 24-well plate at a density of 2 × 104 cells per well. The cells were treated with 0.5 mg/mL (100 μL) DOX-loaded micelle along with 200 μL fresh DMEM media and further incubated at 37°C in 5% CO2 for 4 h. After the incubation, the media was removed, and the cells were washed with PBS three times. The cells were then fixed with 4% paraformaldehyde (incubation for 10 min at room temperature) and washed with PBS (300 μL × 2). After that, the nucleus was counter-stained with 4′,6-diamidino-2-phenylindole (DAPI, blue) according to the manufacturer’s recommended protocol. The images were taken using the BioTek Cytation 3 fluorescent microscope to determine the cellular uptake of micelles.

3 Result and discussion

3.1 Synthesis of amphiphilic diblock copolymers

Amphiphilic diblock copolymers were prepared by sequential monomer addition through ROP using organocatalysts TBD and BnOH initiator (Figure 1). The hydrophilic block is comprised of γ-ME3CL monomer. The hydrophilic ME3 substituents contributed to the thermoresponsivity of the amphiphilic diblock copolymers and, therefore, to the micelles. (; ; ; ; ; ). The hydrophobic blocks consist of three different γ-aromatic group functionalized ε-caprolactone monomers with variable flexibility (Figure 1). The flexibility of the hydrophobic monomers decreases in the order of γ-BnCL > γ-EtOPhCL > γ-PhCL. The monomers γ-ME3CL, (; ), γ-BnCL, (; ), and γ-PhCL () were synthesized according to literature. The new monomer γ-EtOPhCL was synthesized by reacting 4-(4-hydroxyphenyl)cyclohexan-1-one with bromoethane and potassium carbonate to produce 4-(4-ethoxyphenyl)cyclohexan-1-one, which was then purified using column chromatography. Treatment with 77% mCPPBA was subjected to Baeyer–Villiger oxidation to form γ-4-ethoxyphenyl ε-caprolactone (γ-EtOPhCL). The structure of γ-EtOPhCL was characterized by 1H and 13C NMR (Supplementary Figures S1–S7). The structure of this monomer was further confirmed by GC-MS analysis. (Supplementary Figure S8).

FIGURE 1

The synthesized amphiphilic diblock copolymers were characterized by 1H and 13C NMR analysis (Supplementary Figures S9–S14). The composition and molecular mass of the copolymers are summarized in Table 1. The estimated molecular mass from 1H NMR were calculated by multiplying the degree of polymerization (DPn) of polymers with the molecular mass of monomers and then adding the molecular mass of the initiator. The DPn of PME3CL-b-PBnCL was determined by the ratio of the integrations of the methoxy protons of ME3 group on the hydrophilic block (∼3.4 ppm), the methylene protons of benzyl substituent on the hydrophobic block (∼4.5 ppm), and the methylene protons of the benzyl end group of the initiator (∼5.1 ppm). The DPn of PME3CL-b-PPhCL and PME3CL-b-PEtOPhCL were determined by the ratio of integrations of the methoxy protons of ME3 group on the hydrophilic block, the proton of the tertiary carbon on the hydrophobic block backbone (∼2.5 ppm), and the methylene protons of the benzyl end group of the initiator.

TABLE 1

PolymerFeed ratio (mol%)Measured ratioa (mol%)Mna (kDa)Mnb (kDa)PDIb (Mw/Mn)
PME3CL-b-PBnCL50:5046:5435.75.61.67
PME3CL-b-PPhCL50:5045:5525.49.61.95
PME3CL-b-PEtOPhCL50:5047:5336.69.31.95

Molecular mass and components of synthesized amphiphilic diblock copolymers.

a

Calculated by 1H NMR spectra.

b

Determined by size exclusion chromatography (SEC).

The molecular mass determined by size exclusion chromatography (SEC) (Supplementary Figure S15) are lower than those estimated by 1H NMR. This discrepancy may arise from differences in the hydrodynamic volumes of the polymers and the poly(methyl methacrylate) standard used for calibration. The polydispersity index (PDI) of the synthesized diblock copolymers varies from 1.67–1.95. Differential scanning calorimetry (DSC) suggests all three diblock copolymers are amorphous (Supplementary Figures S16). The glass transition temperature (Tg) of the hydrophilic block PME3CL is −80°C, comparable to the reported −82°C. (). The Tg of hydrophobic block PBnCL is −51°C, slightly lower than those of PPhCL (−47°C) and PEtOPhCL (−48°C). This can be attributed to the difference of flexibility and chemical structures among these polymers. The benzyl group of PBnCL is attached to PCL backbone with an ether linkage, while the phenyl group of PPhCL and 4-ethoxyphenyl group of PEtOPhCL are directly connected to the PCL backbone.

3.2 Determination of thermoresponsivity (LCST)

Functional polycaprolactone polymers containing ME3 substituents were reported to have lower critical solution temperature (LCST), above which the polymers underwent phase transition to become less soluble in aqueous solutions. (; ; ; ; ). Temperature-controlled UV-Vis spectrometer is commonly utilized to reveal the thermoresponsivity of the synthesized diblock copolymers. The LCST is taken as the temperature at which the transmittance drops 50%. (; ; ). After the direct dissolution of polymers in PBS (1×, pH = 7.4) (1 mg/mL) and equilibration for 24 h, the aqueous polymer solutions were taken into a temperature-controlled UV-Vis spectrometer. The LCST values of PME3CL-b-PBnCL, PME3CL-b-PPhCL, and PME3CL-b-PEtOPhCL are 74.2°C, 43.3°C, and 37.3°C, respectively (Figures 2A–C). Notably, PME3CL-b-PPhCL and PME3CL-b-PEtOPhCL bearing less flexible aromatic substituents exhibited shaper phase transition and lower LCST. The lowest LCST of PME3CL-b-PEtOPhCL is attributed to the highest hydrophobicity of the polymer. (; ).

FIGURE 2

3.3 Determination of thermodynamic stability (CMC)

Amphiphilic diblock copolymers can self-assemble in aqueous solutions above their CMC to form core-shell structured micelles. (; ). The CMC is an important parameter to determine the thermodynamic stability of polymeric micelles for drug delivery applications because the micelles with higher CMC values disassemble immediately upon substantial dilution after intravenous injection into the bloodstream. (; ). Empty micelles were prepared by a solvent evaporation method. Briefly, a polymer solution in THF was added dropwise to PBS (1×, pH = 7.4) with homogenization. Empty micelle aqueous solutions were obtained after evaporation of THF by vortex and filtration with a 0.45 µm nylon filter. The CMC of PME3CL-b-PBnCL, PME3CL-b-PPhCL, and PME3CL-b-PEtOPhCL were determined using pyrene as a hydrophobic fluorescence probe. Aqueous polymer solutions in PBS with varying polymer concentrations and constant pyrene were analyzed by fluorescence spectrometer. The abrupt change in the ratio of fluorescence intensities at wavelengths of 337.5 nm and 334.5 nm was used to determine the CMC. The CMC values of PME3CL-b-PBnCL, PME3CL-b-PPhCL, and PME3CL-b-PEtOPhCL are 8.8 × 10−4 g/L, 8.7 × 10−4 g/L, and 8.9 × 10−4 g/L, respectively (Figures 2D–F). There is no significant difference in CMC values of the synthesized diblock copolymers due to their similar chemical structures. However, the lower CMC values imply that the self-assembled micelles are stable even at lower concentrations.

3.4 Size and morphology of micelles

The empty micelle sizes were determined by DLS (Figures 3A, D, G), which are 25.30 nm, 26.94 nm, and 34.15 nm for PME3CL-b-PBnCL, PME3CL-b-PPhCL, and PME3CL-b-PEtOPhCL, respectively (Table 2). The empty micelle sizes increase in the order of PME3CL-b-PBnCL, PME3CL-b-PPhCL, and PME3CL-b-PEtOPhCL. This is expected since the more flexible benzyl functional groups arrange themselves to form compact micelles. Compared to the most rigid phenyl group, the less rigid 4-ethyoxyphenyl group is more sterically hindered due to the additional ethoxy group at the para-position, which may further hinder the arrangement of the 4-ethoxyphenyl groups in micellar core, resulting in larger micelles. TEM images showed the formation of spherical micelles and smaller sizes (Figures 3B, E, H). This is because micelles get dehydrated when preparing TEM samples.

FIGURE 3

TABLE 2

PolymerSize in nm (dispersity) aDLC (wt%)DLE (wt%)
Empty micellesDOX-loaded micelles
PME3CL-b-PBnCL25.30 (0.155)49.76 (0.292)3.01 ± 0.1830.10 ± 1.88
PME3CL-b-PPhCL26.94 (0.118)31.96 (0.116)2.31 ± 0.2523.10 ± 2.55
PME3CL-b-PEtOPhCL34.15 (0.196)45.48 (0.173)1.95 ± 0.0519.50 ± 0.50

Properties of empty and DOX-loaded micelles.

a

DLS, was used to determine the hydrodynamic diameter and size dispersity.

3.5 Drug loading with doxorubicin

The potential application of the micelles as drug carriers was tested by loading DOX, an anticancer hydrophobic drug molecule. (; ; ; ; ; ; ; ; Yan et al., 2020; ; ). DOX-loaded micelles were prepared by entrapping the drug in the hydrophobic core using the solvent evaporation method. Similarly, a solution of polymer and DOX in THF was added to the aqueous solution dropwise while homogenizing. DOX-loaded micelle solutions were obtained after filtration by a 0.45 µm nylon filter. Upon loading of DOX, the size of micelles was slightly increased (Figures 3A, D, G). The sizes of DOX-loaded micelles were 49.76 nm, 31.96 nm, and 45.48 nm for PME3CL-b-PBnCL, PME3CL-b-PPhCL, and PME3CL-b-PEtOPhCL, respectively (Table 2). TEM images demonstrated the formation of spherical DOX-loaded micelles (Figures 3C, F, I).

The drug loading capacity of DOX-loaded micelles was determined by UV-Vis spectroscopy. Briefly, DOX-loaded micelles were disassembled by adding an equivalent volume of DMSO, and then the UV-Vis absorbance of the mixture was obtained. The concentration of DOX was determined by fitting the absorbance readings to a pre-plotted calibration curve. Then, the DLC and DLE were calculated using Eqs. 1, 2. PME3CL-b-PBnCL exhibited the highest DLC, while PME3CL-b-PPhCL and PME3CL-b-PEtOPhCL showed lower and comparable DLC. This can be attributed to the flexibility of the aromatic groups on the hydrophobic blocks. Due to higher flexibility, the benzyloxy groups on the PBnCL block can orient themselves to accommodate DOX molecules and enhance the polymer-drug interaction, which is impossible in the other two polymers. The DLC of PEtOPhCL is hampered by considerable steric hindrance of the 4-ethoxy group on the phenyl ring. This limits the polymers’ interaction with DOX, resulting in a low loading of DOX into the PME3CL-b-PEtOPhCL micellar core.

3.6 Drug release profile

The in vitro release of DOX from the micelles was studied in PBS (pH 7.4) at a physiological temperature (37°C) to compare the effect of the hydrophobic aromatic side chain (Figure 4). The initial release rate of PME3CL-b-PEtOPhCL micelles was higher than that of the PME3CL-b-PBnCL and PME3CL-b-PPhCL micelles, which confirms that the polymer with a lower LCST shows a faster release profile. The overall release of the PME3CL-b-PEtOPhCL micelles was the highest, achieving a cumulative release of 60% after 8 h. This is attributed to its LCST being closest to the physiological temperature. (; ). The release study indicates that the DOX release of the reported thermoresponsive polymeric micelles is affected by their LCST values and that the drug release can be adjusted by varying the hydrophobic aromatic functional groups on the polymers.

FIGURE 4

3.7 Toxicity assessment

Cytotoxicity measurements were conducted on MDA-MB-231 breast cancer cells using various concentrations of empty micelles to assess polymer biocompatibility. The cell viability was examined by MTT assay, followed by the cells had been exposed to the polymer solutions for 24 h. The empty micelles were not shown to exhibit significant toxicity to the cells even up to 0.5 mg/mL (Figure 5A). The cytotoxicity measurements demonstrate that polymers are excellent biocompatible materials for drug delivery applications.

FIGURE 5

To test the cytotoxicity of DOX-loaded micelles, the micelles were loaded into MDA-MB-231 cells and incubated for 24 h under 37°C and 5% CO2. It was observed at all concentrations that the release of DOX was more significant to the drug loading capacity at physiological temperatures. The DOX-loaded PME3CL-b-PBnCL micelles exhibited higher toxicity than the DOX-loaded PME3CL-b-PEtOPhCL micelles, which can be attributed to the increased loading capabilities of the PME3CL-b-PBnCL micelles (Figure 5B).

3.8 Cellular uptake

Cellular uptake of DOX-loaded micelles was performed using MDA-MB-231 cells at 37°C. The cells were introduced with the DOX-loaded micelles and incubated for 4 h. After fixing the cells, the cell nuclei were stained with DAPI and visualized through Cytation 3 fluorescent microscope (Figure 6). The data reveals that the DOX-loaded micelles were preferentially accumulated into the cells, and the DOX were internalized within the nucleus of the cells. Moreover, the cells incubated with PME3CL-b-PEtOPhCL showed a slightly higher DOX internalization into the nucleus when compared to the cells incubated with PME3CL-b-PBnCL and PME3CL-b-PPhCL at 37°C. This further confirms that the micelles with higher LCST values were less uptaken than those with the closest LCST to the physiological temperature. The red signal, attributed to DOX, can be seen within the cell nuclei, indicating the endocytosis of the micelles into the cell and the internalization of DOX into the nucleus of the cell.

FIGURE 6

4 Conclusion

Three γ−functionalized PCL amphiphilic diblock copolymers with varying hydrophobic aromatic substituents (PME3CL-b-PBnCL, PME3CL-b-PPhCL, and PME3CL-b-PEtOPhCL) were synthesized. All three diblock copolymers are amorphous and can form thermodynamically stable spherical micelles with comparable CMC. Their potential usage as drug carriers was assessed by loading with DOX. PME3CL-b-PBnCL exhibited the highest DLC, while PME3CL-b-PPhCL and PME3CL-b-PEtOPhCL showed lower DLC due to higher structural rigidity and larger steric hindrance. However, the LCST values of these two polymers were closer to physiological temperature, and their DOX-loaded micelles exhibited faster drug release. All three amphiphilic diblock copolymers were shown to have minimal toxicity on MDA-MB-231 breast cancer cells up to a concentration of 0.5 mg/mL. In vitro studies also confirmed that the cells were less viable at higher concentrations of DOX-loaded micelles. In this work, a systematic study of the effect of analogous aromatic functional groups on the self-assembly behaviors of γ-functionalized PCL amphiphilic diblock copolymers and the delivery of anticancer drug DOX was reported. In the future, we plan to investigate the influence of different linkages (such as ether, ester, and amide), which connect the functional groups and the polymer backbone, on the performance of amphiphilic functional PCL micellar carriers for the delivery of anticancer drugs.

Statements

Data availability statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding authors.

Author contributions

HW: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Writing–original draft, Writing–review and editing. HP: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Writing–original draft, Writing–review and editing. AB: Conceptualization, Data curation, Investigation, Methodology, Writing–original draft, Writing–review and editing. TS: Data curation, Investigation, Writing–review and editing. GB: Data curation, Investigation, Writing–review and editing. ZM: Data curation, Investigation, Writing–original draft, Writing–review and editing. EC: Data curation, Investigation, Formal Analysis, Writing–original draft, Writing–review and editing. JM: Data curation, Investigation, Formal Analysis, Writing–original draft, Writing–review and editing. MB: Conceptualization, Data curation, Funding acquisition, Investigation, Methodology, Resources, Supervision, Validation, Writing–original draft, Writing–review and editing. MS: Conceptualization, Supervision, Writing–original draft, Writing–review and editing.

Funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The publication cost was funded (or partially funded) by The University of Texas at Dallas Office of Research and Innovation through the GRaCE grant program.

Acknowledgments

Financial support from the Welch Foundation (AT-1740) and National Science Foundation (CHE-1609880) is gratefully acknowledged. M. C. S. thanks the endowed chair support from the Eugene McDermott Foundation. This project was funded (or partially funded) by The University of Texas at Dallas Office of Research and Innovation through the GRaCE grant program.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphar.2024.1356639/full#supplementary-material

References

  • 1

    Ahmad ShariffS. H.Wan Abdul KhodirW. K.Abd HamidS.HarisM. S.IsmailM. W. (2022). Poly (caprolactone)-b-poly (ethylene glycol)-based polymeric micelles as drug carriers for efficient breast cancer therapy: a systematic review. Polymers14 (22), 4847. 10.3390/polym14224847

  • 2

    BhadranA.PolaraH.CalubaquibE.WangH.BabanyinahG.ShahT.et al (2023a). Reversible cross-linked thermoresponsive polycaprolactone micelles for enhanced stability and controlled release. Biomacromolecules24 (12), 58235835. 10.1021/acs.biomac.3c00832

  • 3

    BhadranA.ShahT.BabanyinahG. K.PolaraH.TaslimyS.BiewerM. C.et al (2023b). Recent advances in polycaprolactones for anticancer drug delivery. Pharmaceutics15 (7), 1977. 10.3390/pharmaceutics15071977

  • 4

    CalubaquibE. L.SoltantabarP.WangH.ShinH.FloresA.BiewerM. C.et al (2021). Self-assembly behavior of oligo (ethylene glycol) substituted polycaprolactone homopolymers. Polym. Chem.12 (24), 35443550. 10.1039/d1py00483b

  • 5

    ChenW.MengF.ChengR.DengC.FeijenJ.ZhongZ. (2015). Biodegradable glycopolymer-b-poly(ε-caprolactone) block copolymer micelles: versatile construction, tailored lactose functionality, and hepatoma-targeted drug delivery. J. Mater Chem. B3 (11), 23082317. 10.1039/c4tb01962h

  • 6

    ChengY.HaoJ.LeeL. A.BiewerM. C.WangQ.StefanM. C. (2012). Thermally controlled release of anticancer drug from self-assembled γ-substituted amphiphilic poly (ε-caprolactone) micellar nanoparticles. Biomacromolecules13 (7), 21632173. 10.1021/bm300823y

  • 7

    ChuanZ.WangY.ZhaoY.LiuH.ZhaoY.LiX.et al (2019). Biodegradable micelles for NIR/GSH-Triggered chemophototherapy of cancer. Nanomaterials9 (1), 91. 10.3390/nano9010091

  • 8

    DaiW.HuangH.DuZ.LangM. (2008). Synthesis, characterization and degradability of the novel aliphatic polyester bearing pendant N-isopropylamide functional groups. Polym. Degrad. Stab.93 (12), 20892095. 10.1016/j.polymdegradstab.2008.09.001

  • 9

    DengX.YuanM.CaoX.LiX. (2001). Polymerization of Lactides and Lactones, 8. Study on the ring‐opening polymerization of 3‐Phenyl‐ε‐caprolactone and 5‐Phenyl‐ε‐caprolactone. Macromol. Chem. Phys.202 (11), 24172424. 10.1002/1521-3935(20010701)202:11<2417::aid-macp2417>3.0.co;2-c

  • 10

    DouJ.YuS.ReddyO.ZhangY. (2023). Novel ABA block copolymers: preparation, temperature sensitivity, and drug release. Rsc Adv.13 (1), 129139. 10.1039/d2ra05831f

  • 11

    GhasemiS.OwrangM.JavaheriF.FarjadianF. (2022). Spermine modified PNIPAAm nano-hydrogel serving as thermo-responsive system for delivery of cisplatin. Macromol. Res.30 (5), 314324. 10.1007/s13233-022-0035-7

  • 12

    GlavasL.OdeliusK.AlbertssonA. C. (2015). Tuning loading and release by modification of micelle core crystallinity and preparation. Polym. Adv. Technol.26 (7), 880888. 10.1002/pat.3524

  • 13

    HaoJ.ChengY.RanatungaR. J. K. U.SenevirathneS.BiewerM. C.NielsenS. O.et al (2013). A combined experimental and computational study of the substituent effect on micellar behavior of γ-substituted thermoresponsive amphiphilic poly(ε-caprolactone)s. Macromol. Wash. D.C. U. S.)46 (12), 48294838. 10.1021/ma400855z

  • 14

    HaoJ.ServelloJ.SistaP.BiewerM. C.StefanM. C. (2011). Temperature-sensitive aliphatic polyesters: synthesis and characterization of γ-substituted caprolactone monomers and polymers. J. Mater. Chem.21 (29), 1062310628. 10.1039/c1jm11288k

  • 15

    HuangY.-T.PengK.-Y.ChiuF.-C.LeeR.-S. (2013). Synthesis of diblock functional poly(ɛ-caprolactone) amphiphilic copolymers grafted with bioactive molecules and characterization of their micelles. Polym. J.45 (9), 962970. 10.1038/pj.2012.233

  • 16

    HusseinY. H.YoussryM. (2018). Polymeric micelles of biodegradable diblock copolymers: enhanced encapsulation of hydrophobic drugs. Materials11 (5), 688. 10.3390/ma11050688

  • 17

    KarmegamV.KuruppuS. S.GedaraC. M. U.BiewerM. C.StefanM. C. (2021). Enhanced DOX loading in star-like benzyl functionalized polycaprolactone micelles. J. Polym. Sci.59 (23), 30403052. 10.1002/pol.20210544

  • 18

    KuperkarK.PatelD.AtanaseL. I.BahadurP. (2022). Amphiphilic block copolymers: their structures, and self-assembly to polymeric micelles and polymersomes as drug delivery vehicles. Polymers14 (21), 4702. 10.3390/polym14214702

  • 19

    LeeR.-S.HuangY.-T.ChenW.-H. (2010). Synthesis and characterization of temperature-sensitive block copolymers from poly(N-isopropylacrylamide) and 4-methyl-ε-caprolactone or 4-phenyl-ε-caprolactone. J. Appl. Polym. Sci.118 (3), 16341642. 10.1002/app.32546

  • 20

    LiZ.LinZ. (2022). Self‐assembly of block copolymers for biological applications. Polym. Int.71 (4), 366370. 10.1002/pi.6327

  • 21

    LiuJ.ZhangY.YanJ.LangM. (2011). Synthesis and solution properties of pH responsive methoxy poly(ethylene glycol)-b-poly(γ-amino-ε-caprolactone). J. Mater. Chem.21 (18), 6677. 10.1039/c1jm10142k

  • 22

    MalhotraM.SurnarB.JayakannanM. (2016). Polymer topology driven enzymatic biodegradation in polycaprolactone block and random copolymer architectures for drug delivery to cancer cells. Macromolecules49 (21), 80988112. 10.1021/acs.macromol.6b01793

  • 23

    PathaA. S.PatilT.PandeyP. K.KucheK.GhadiR.JainS. (2023). “Chapter 7 - block copolymer micelles as long-circulating drug vehicles,” in Smart polymeric nano-constructs in drug delivery. Editors VyasS. P.AgrawalU.SharmaR. (China: Academic Press), 187220.

  • 24

    PengK.-Y.WangS.-W.HuaM.-Y.LeeR.-S. (2013). Amphiphilic photocleavable block copolymers based on monomethyl poly (ethylene glycol) and poly (4-substituted-ε-caprolactone): synthesis, characterization, and cellular uptake. RSC Adv.3 (40), 1845318463. 10.1039/c3ra42763c

  • 25

    PerumalS.AtchudanR.LeeW. (2022). A review of polymeric micelles and their applications. Polymers14 (12), 2510. 10.3390/polym14122510

  • 26

    QiaoY.ZhanC.WangC.ShiX.YangJ.HeX.et al (2020). MMP-2 sensitive poly (malic acid) micelles stabilized by π–π stacking enable high drug loading capacity. J. Mater. Chem. B8 (37), 85278535. 10.1039/d0tb01682a

  • 27

    RainboltE. A.MillerJ. B.WashingtonK. E.SenevirathneS. A.BiewerM. C.SiegwartD. J.et al (2015b). Fine-tuning thermoresponsive functional poly (ε-caprolactone) s to enhance micelle stability and drug loading. J. Mater. Chem. B3 (9), 17791787. 10.1039/c4tb02016b

  • 28

    RainboltE. A.WashingtonK. E.BiewerM. C.StefanM. C. (2015a). Recent developments in micellar drug carriers featuring substituted poly(ε-caprolactone)s. Polym. Chem.6 (13), 23692381. 10.1039/c4py01628a

  • 29

    SenevirathneS. A.BoonsithS.OupickyD.BiewerM. C.StefanM. C. (2015). Synthesis and characterization of valproic acid ester pro-drug micelles via an amphiphilic polycaprolactone block copolymer design. Polym. Chem.6 (13), 23862389. 10.1039/c4py01808g

  • 30

    SenevirathneS. A.WashingtonK. E.MillerJ. B.BiewerM. C.OupickyD.SiegwartD. J.et al (2017a). HDAC inhibitor conjugated polymeric prodrug micelles for doxorubicin delivery. J. Mater. Chem. B5 (11), 21062114. 10.1039/C6TB03038F

  • 31

    SenevirathneS. A.WashingtonK. E.MillerJ. B.BiewerM. C.OupickyD.SiegwartD. J.et al (2017b). HDAC inhibitor conjugated polymeric prodrug micelles for doxorubicin delivery. J. Mater Chem. B5 (11), 21062114. 10.1039/C6TB03038F

  • 32

    ShahT.VasavaD. (2019). A glimpse of biodegradable polymers and their biomedical applications. e-Polymers19 (1), 385410. 10.1515/epoly-2019-0041

  • 33

    ShiY.van SteenbergenM. J.TeunissenE. A.NovoL. s.GradmannS.BaldusM.et al (2013). Π–Π stacking increases the stability and loading capacity of thermosensitive polymeric micelles for chemotherapeutic drugs. Biomacromolecules14 (6), 18261837. 10.1021/bm400234c

  • 34

    SoltantabarP.CalubaquibE. L.MostafaviE.BiewerM. C.StefanM. C. (2020). Enhancement of loading efficiency by coloading of doxorubicin and Quercetin in thermoresponsive polymeric micelles. Biomacromolecules21 (4), 14271436. 10.1021/acs.biomac.9b01742

  • 35

    SongC.YangF.JiR.LvY.WeiZ. (2021). Construction of a drug delivery system via pH-responsive polymeric nanomicelles containing ferrocene for DOX release and enhancement of therapeutic effects. ACS Omega6 (42), 2824228253. 10.1021/acsomega.1c04330

  • 36

    SurnarB.JayakannanM. (2016). Structural engineering of biodegradable PCL block copolymer nanoassemblies for enzyme-controlled drug delivery in cancer cells. ACS Biomaterials Sci. Eng.2 (11), 19261941. 10.1021/acsbiomaterials.6b00310

  • 37

    TakahashiA.OzakiY.KuzuyaA.OhyaY. (2014). Impact of core-forming segment structure on drug loading in biodegradable polymeric micelles using PEG-b-poly (lactide-co-depsipeptide) block copolymers. BioMed Res. Int.2014, 579212. 10.1155/2014/579212

  • 38

    WangQ.AtluriK.TiwariA. K.BabuR. J. (2023). Exploring the application of micellar drug delivery systems in cancer nanomedicine. Pharm. (Basel)16 (3), 433. 10.3390/ph16030433

  • 39

    WashingtonK. E.KularatneR. N.BiewerM. C.StefanM. C. (2018a). Combination loading of doxorubicin and resveratrol in polymeric micelles for increased loading efficiency and efficacy. ACS Biomaterials Sci. Eng.4 (3), 9971004. 10.1021/acsbiomaterials.7b00972

  • 40

    WashingtonK. E.KularatneR. N.BiewerM. C.StefanM. C. (2018b). Combination loading of doxorubicin and resveratrol in polymeric micelles for increased loading efficiency and efficacy. ACS Biomater. Sci. Eng.4 (3), 9971004. 10.1021/acsbiomaterials.7b00972

  • 41

    WashingtonK. E.KularatneR. N.DuJ.RenY.GillingsM. J.GengC. X.et al (2017). Thermoresponsive star-like γ-substituted poly(caprolactone)s for micellar drug delivery. J. Mater. Chem. B5 (28), 56325640. 10.1039/c7tb01291h

  • 42

    WenL.ZhangS.XiaoY.HeJ.ZhuS.ZhangJ.et al (2020). Organocatalytic ring-opening polymerization toward poly(γ-amide-ε-caprolactone)s with tunable lower critical solution temperatures. Macromolecules53 (13), 50965104. 10.1021/acs.macromol.0c00253

  • 43

    YanE. Y.JiangJ. Y.YangX. Y.FanL. Q.WangY. W.AnQ. L.et al (2020). pH-sensitive core-shell electrospun nanofibers based on polyvinyl alcohol/polycaprolactone as a potential drug delivery system for the chemotherapy against cervical cancer. J. Drug Deliv. Sci. Technol.55, 101455. 10.1016/j.jddst.2019.101455

  • 44

    YanJ.YeZ.ChenM.LiuZ.XiaoY.ZhangY.et al (2011). Fine tuning micellar core-forming block of poly (ethylene glycol)-block-poly (ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin. Biomacromolecules12 (7), 25622572. 10.1021/bm200375x

  • 45

    YanJ.ZhangY.XiaoY.ZhangY.LangM. (2010). Novel poly(ε-caprolactone)s bearing amino groups: synthesis, characterization and biotinylation. React. Funct. Polym.70 (7), 400407. 10.1016/j.reactfunctpolym.2010.03.008

  • 46

    ZhangY.LiJ.DuZ.LangM. (2014). Synthesis and pH-responsive assembly of methoxy poly(ethylene glycol)-b -poly(ε-caprolactone) with pendant carboxyl groups. J. Polym. Sci. Part A Polym. Chem.52 (2), 188199. 10.1002/pola.26987

Summary

Keywords

functionalized polycaprolactone, amphiphilic diblock copolymers, thermoresponsive polymers, polymeric micelles, drug delivery

Citation

Wang H, Polara H, Bhadran A, Shah T, Babanyinah GK, Ma Z, Calubaquib EL, Miller JT, Biewer MC and Stefan MC (2024) Effect of aromatic substituents on thermoresponsive functional polycaprolactone micellar carriers for doxorubicin delivery. Front. Pharmacol. 15:1356639. doi: 10.3389/fphar.2024.1356639

Received

15 December 2023

Accepted

19 January 2024

Published

04 March 2024

Volume

15 - 2024

Edited by

Catalin Zaharia, Polytechnic University of Bucharest, Romania

Reviewed by

Philippe Lecomte, University of Liège, Belgium

Xuefang Hao, Inner Mongolia University for Nationalities, China

Updates

Copyright

*Correspondence: Mihaela C. Stefan, ; Michael C. Biewer,

†These authors have contributed equally to this work

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics